期刊文献+

Triptorelin和Buserelin对不孕妇女体外受精一胚胎移植疗效的比较 被引量:3

Comparison between Triptorelin and Buserelin for in vitro fertilization program.
下载PDF
导出
摘要 目的 比较GnRH -a制剂Triptorelin和Buserelin的体外受精—胚胎移植治疗效果。方法  185例不孕妇女随机分成两组 ,A组 :85例 ,黄体期应用Triptorelin(月经第 2 1d皮下一次性注射 1.2 5~ 1.6 0mg) ;B组 :10 0例 ,黄体期应用Buserelin。两组均用长方案降调节。比较两组的高纯度促卵泡刺激素用药剂量、取卵数、受精率、卵裂率和妊娠率。结果 两组的取卵数、受精率、卵裂率和妊娠率无显著性差异 (P >0 .0 5 )。A组平均每周期用高纯度卵泡刺激素 4 0 .3± 18.2支 ,B组平均每周期用 30 .2± 12 .3支 ,有显著性差异 (P <0 .0 1)。结论 Triptorelin和Buserelin的长方案均可获得高质量的成熟卵子 ,对不孕妇女的体外受精—胚胎移植治疗效果相似。Triptorelin的降调节作用较Buserelin的强。黄体期一次性皮下注射Triptorelin1.2 5~ 1.6 0mg可简化治疗过程 ,患者易于接受。 Objective: To compare the effects of GnRH agonists, Triptorelin and Buserelin, on the treatment of infertile women in in vitro fertilization(IVF) cycles. Methods: 185 infertile women were randomly divided into Triptorelin group (group A, 85 cases) and Buserelin grouup (group B, 100 cases). In group A each case was subcutaneously injected 1.25~1.60mg Triptorelin on the day 21 of the luteal phase. In group B each case was given 600μg Buserelin daily by nasal spray start in the day 21 of the luteal phase continue till hCG was given. Both groups were treated by the management with long-term GnRH down-regulation. Results: There were no significant difference on the number of oocyte obtained, fertilization rates, cleavage rates, and clinical pregnancy rates between these two groups (P>0.05). The dosage of highly purified follicular stimulating hormone in group A was more than that in group B (P<0.01). Conclusion: Triptorelin and Buserelin would have the similar efficacy in IVF treatment, and contribute the similar clinical pregnancy rates. Triptorelin has stronger effect on pituitary down-regulation than Buserelin. The Triptorelin protocol is simple, and patients would be easily treated.
出处 《中国优生与遗传杂志》 2003年第3期110-111,105,共3页 Chinese Journal of Birth Health & Heredity
关键词 超排卵 体外受精 TRIPTORELIN BUSERELIN In vitro fertilization Superovulation Triptorelin Buserelin
  • 相关文献

参考文献5

  • 1朱伟杰,邢福祺,吴日然,张柱林,徐建亚,廖月婵,吴嘉齐,白宝敏.中山地区应用体外受精技术治疗不育症的初步报告[J].中国优生与遗传杂志,2001,9(6):104-105. 被引量:4
  • 2Akagbosu FT. The use of GnRH agonists and antagonists in infertility. In: A textbook of in vitro fertilization and assisted reproduction.Brinsden PR ed. Parthenon Publishing Group, New York, 1999:83-90.
  • 3Reissmann T, Felberbaum R, Diedrich K, et al. Development and applications of lutelnising hormone - releasing hormone antagonists in the treatment of infertility: an overview. Hum Reprod, 1995, 10:1974 - 1981.
  • 4Loumaye M, Brinsden PR. Superovulation strategies in assisted conception. In: A textbook of in vitro fertilization and assisted reproduction. Brinsden PRed. Parthenon Publishing Group, New York, 1999:91 - 102.
  • 5Loumaye E. The control of endogenous secretion of LH bygonadotrophin- releasing hormone agonists during ovrian hyperstimulation for in vitro fertilization and embryo transfer. Hum Reprod, 1990, 5 : 357 - 376.

二级参考文献1

共引文献3

同被引文献17

  • 1Luisi S, Florio P, Reis FM,et al. Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy.Hum Reprod Update, 2005,11:123-135.
  • 2Hazout A, Bouchard P, Seifer DB,et al. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril, 2004,82:1323-1329.
  • 3Laven JS, Fauser BC. Inhibins and adult ovarian function. Mol Cell Endocrinol, 2004,225:37-44.
  • 4Penarrubia J, Balasch J, Fabregues F, et al. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod, 2000,15:1499-1504.
  • 5Hohmann FP, Laven JS, de Jong FH, et al. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women. Eur J Endocrinol, 2005,152:395-401.
  • 6Hofmann GE, Danforth DR, Seifer DB. Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril, 1998,69:474-477.
  • 7Urbancsek J, Hauzman E, Klinga K, et al. Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome. Fertil Steril, 2005,83:341-348.
  • 8罗丽兰 刘义 高颖.子宫内膜异位症与不孕[A].罗丽兰主编.不孕与不育[C].人民卫生出版社,1998.306-256.
  • 9Matorras R, Rodiques F, Pigion JI, et al. Epidemiology of endometriosis among infertile women. Fertil Steril, 1995,63(1):34-39.
  • 10Gerbie AB, Merill JA. Pathology of endometriosis. Clin obstet Gynecol, 1988,31(5):779-813.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部